Health
ADB launches $9 billion vaccine initiative for Developing Asia
ADB’s $9 billion vaccine initiative, the Asia Pacific Vaccine Access Facility, or APVAX, will provide a comprehensive program to support developing Asia’s vaccine process.
MANILA, PHILIPPINES (11 December 2020) — The Asian Development Bank (ADB) has launched a $9 billion vaccine initiative—the Asia Pacific Vaccine Access Facility (APVAX)—offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines.
“As ADB’s developing members prepare to vaccinate their people as soon as possible, they need financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably, and efficiently manage the vaccination process,” said ADB President Masatsugu Asakawa. “APVAX will play a critical role in helping our developing members meet these challenges, overcome the pandemic, and focus on economic recovery.”
More than 14.3 million positive cases have been identified in Asia and the Pacific, causing more than 200,000 deaths. As the pandemic persists, economic growth in developing Asia is projected to contract by 0.4% in 2020—the first regional gross domestic product contraction since the early 1960s.
Promoting safe, equitable, and effective access to vaccines is a top priority for ADB’s COVID-19 response efforts. Vaccination programs can break the chain of virus transmission, save lives, and mitigate the negative economic impacts of the pandemic by restoring confidence in people’s ability to work, travel, and socialize safely.
The APVAX provides a comprehensive framework and resource envelope for supporting developing Asia’s vaccine access, using two complementary components. The Rapid Response Component will provide timely support for critical vaccine diagnostics, procurement of vaccines, and transporting vaccines from the place of purchase to ADB’s developing members.
The Project Investment Component will support investments in systems for successful distribution, delivery, and administration of vaccines along with associated investments in building capacity, community outreach, and surveillance. This may include such areas as cold-chain storage and transportation, vehicles, distribution infrastructure, processing facilities, and other physical investments. The component may also be used to develop or expand vaccine manufacturing capacity in developing members.
ADB financing for vaccines will be provided in close coordination with other development partners including the World Bank Group, World Health Organization (WHO), COVID-19 Vaccines Global Access Facility (COVAX), GAVI, and bilateral and multilateral partners.
Health
Thailand approves COVID-19 AstraZeneca vaccine for emergency use
The first lot of 50,000 doses of COVID-19 vaccine developed by AstraZeneca will arrive in Thailand early next month, after receiving approval from the country’s Food and Drug Administration (FDA).
Health
Covid-19: the Latest on Southeast Asia
As 2021 dawns, the coronavirus pandemic continues to develop in Southeast Asia. Many countries are preparing to receive their first vaccine shipments, and a few have already started distributing them.

As 2021 dawns, the coronavirus pandemic continues to develop in Southeast Asia. Many countries are preparing to receive their first vaccine shipments, and a few have already started distributing them.
(more…)Health
Thailand strengthens COVID-19 control measures
Apart from the capital city, many provinces have also enforced tougher measures to contain COVID-19, with inter-provincial travels now being restricted in some areas.

According to the Tourism Authority of Thailand (TAT) latest update regarding the Royal Thai Government’s announcement on the strengthened COVID-19 control measures to contain local transmission, 28 provinces are now declared as “highly controlled areas”.
(more…)- Economics6 days ago
Thai economy to grow 4% in 2021 following 6.5% decline in 2020
- National6 days ago
Human trafficking cases in Thailand hit decade low due to COVID-19
- Banking1 week ago
Can Fintech drive a strong post-COVID-19 recovery in Asia?
- Health1 day ago
Thailand approves COVID-19 AstraZeneca vaccine for emergency use